Bio-Kult Migréa is a scientifically developed, advanced multi-action probiotic designed to target the digestive tract and the head.
A recent clinical trial found that the 14 strains of live bacteria in Bio-Kult Migréa, significantly reduced both episodic and chronic migraine frequency and severity and reliance on medication in as little as eight weeks. It contains magnesium and vitamin B6 both of which contribute to the normal functioning of the nervous system, and the reduction of tiredness and fatigue (which often accompany migraine attacks).
Commenting on the new launch, Jonathan Sowler, Managing Director at ADM Protexin, which manufactures Bio-Kult, explained: “Migraine is the leading cause of disability among all neurological disorders, with more than 50 per cent of migraine sufferers unhappy with their current treatment. We’re excited to bring this scientifically developed product to the market backed by clinical research to give sufferers a natural option.